|
|
Volumn 102, Issue 22, 2010, Pages 1692-1694
|
|
Of Ephs and ephrins: companies target guidance molecules in cancer.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
EPHRIN;
EPHRIN RECEPTOR;
ANIMAL;
DRUG DESIGN;
DRUG EFFECT;
ENZYMOLOGY;
HUMAN;
METABOLISM;
NEOPLASM;
NOTE;
SIGNAL TRANSDUCTION;
ANIMALS;
ANTINEOPLASTIC AGENTS;
DRUG DESIGN;
EPHRINS;
HUMANS;
NEOPLASMS;
RECEPTORS, EPH FAMILY;
SIGNAL TRANSDUCTION;
|
|
EID: 79952111485
PISSN: None
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djq479 Document Type: Note |
|
Times cited : (21)
|
|
References (0)
|
